| US11872214B2 | 16 January 2024 | Grant | US18081251 | Formulations of bendamustine | Eagle Pharmaceuticals Inc |
|---|
| US11844783B2 | 19 December 2023 | Grant | US18081238 | Formulations of bendamustine | Eagle Pharmaceuticals Inc |
|---|
| US11819550B2 | 21 November 2023 | Grant | US17067058 | Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP) | Eagle Biologics Inc |
|---|
| US11793813B2 | 24 October 2023 | Grant | US17835236 | Pemetrexed formulations | Eagle Pharmaceuticals Inc |
|---|
| US11590077B2 | 28 February 2023 | Grant | US16762229 | Fulvestrant formulations and methods of their use | Eagle Pharmaceuticals Inc |
|---|
